Case is first to show safety and effectiveness of using infection-fighting T cells alone to put late-stage melanoma into long-term remission
June 23, 2008
| By Dean Forbes
Scientists from Fred Hutchinson Cancer Research Center describe the first successful use of a human patient’s cloned infection-fighting T-cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.